ArticleJournal for immunotherapy of cancer2021

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.

Brendan D Curti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.